TVGN

Tevogen Bio Holdings Inc. is a clinical-stage specialty immunotherapy company developing off-the-shelf, genetically unmodified T cell therapeutics. The company focuses on treating infectious diseases, cancers, and neurological disorders using its proprietary ExacTcell technology platform. Tevogen aims to make personalized cellular immunotherapy more accessible and affordable.